Robert Baran

ORCID: 0000-0001-8858-2022
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nail Diseases and Treatments
  • Cutaneous lymphoproliferative disorders research
  • Plant Pathogens and Fungal Diseases
  • Fungal Infections and Studies
  • Autoimmune Bullous Skin Diseases
  • Cancer and Skin Lesions
  • Nonmelanoma Skin Cancer Studies
  • Infectious Diseases and Mycology
  • Genetic and rare skin diseases.
  • Soft tissue tumors and treatment
  • Contact Dermatitis and Allergies
  • Dupuytren's Contracture and Treatments
  • Skin and Cellular Biology Research
  • Chemotherapy-related skin toxicity
  • Tumors and Oncological Cases
  • Dermatological and Skeletal Disorders
  • Vascular Malformations and Hemangiomas
  • Orthopedic Surgery and Rehabilitation
  • Soft tissue tumor case studies
  • Dermatology and Skin Diseases
  • Oral Health Pathology and Treatment
  • Surgical Sutures and Adhesives
  • Congenital limb and hand anomalies
  • Vascular Tumors and Angiosarcomas
  • Musculoskeletal synovial abnormalities and treatments

Centre Hospitalier de Cannes
2015-2024

Queen Fabiola Children's University Hospital
2022

Centre Hospitalier Universitaire Brugmann
2022

Centre Hospitalier Universitaire de Saint-Pierre
2022

Pitié-Salpêtrière Hospital
2022

Sorbonne Université
2022

Université Libre de Bruxelles
2022

Université de franche-comté
2001-2021

Institut Gustave Roussy
2001-2017

Agroécologie
2012

Synopsis The nail plate is the permanent product of matrix. Its normal appearance and growth depend on integrity several components: surrounding tissues or perionychium bony phalanx that are contributing to apparatus unit. inserted proximally in an invagination practically parallel upper surface skin laterally lateral grooves. This pocket‐like has a roof, proximal fold floor, matrix from which derived. germinal forms bulk plate. element superficial third whereas distal provides its inferior...

10.1111/j.1467-2494.2007.00372.x article EN International Journal of Cosmetic Science 2007-07-21

To review recent data - what is new in the epidemiology of onychomycoses? identify most relevant diagnostic criteria for effective therapy.The preliminary results European Onychomycosis Observatory (EUROO) study were analysed. In this international study, physicians completed questionnaires concerning patient profile and disease.One interesting novel findings was that sampling requests often not made [only 3.4% general (GPs) 39.6% dermatologists]. This means no information about causative...

10.1111/j.1468-3083.2005.01281.x article EN Journal of the European Academy of Dermatology and Venereology 2005-08-24

Identical lesions of the nails were observed in three patients. The main signs a yellow colouration along entire length nail plate with splinter haemorrhages its proximal portion, tendency towards transverse overcurvature affected nails, and exposure matrix tumour after had been avulsed fold turned back. striking enough to lead clinical suspicion filamentous tufted funnel-shaped nail, an entity not previously described.

10.1111/j.1365-2133.1992.tb11827.x article EN British Journal of Dermatology 1992-05-01

Nail infections caused by Candida species are normally associated with chronic paronychia or mucocutaneous candidiasis (CMCC). However, the role of in pathogenesis other primary nail dystrophies has been questioned view their response to antifungal therapy alone. In present study 86 patients from which was isolated, three patterns involvement were found. Nineteen patients, whom 17 had CMCC, total dystrophic onychomycosis at least two nails. The second group consisted 27 and lateral...

10.1111/j.1365-2133.1988.tb01749.x article EN British Journal of Dermatology 1988-01-01

ABSTRACT Background There are currently three main treatment strategies for onychomycosis: topical, oral and combination. Amorolfine nail lacquer appears to be the most effective form of topical monotherapy. However, best mycological clinical cure rates obtained with combination therapy. Combination therapy increases antifungal spectrum, fungicidal activity safety. New antifungals (triazoles echinocandins) were recently developed, enabling new protocols. Objectives To review available...

10.1111/j.1468-3083.2005.01284.x article EN Journal of the European Academy of Dermatology and Venereology 2005-08-24

10.1016/s0190-9622(87)70291-6 article EN Journal of the American Academy of Dermatology 1987-12-01

Background Onychomycosis is common, accounting for up to 50% of all nail disorders. Toenail onychomycosis can cause deformity, embarrassment, pain and walking difficulties. Some populations, such as individuals with diabetes, are at higher risk developing secondary complications infections. Treatment takes many months therapeutic choices increase clinical effectiveness, lower toxicity minimize healthcare costs. Objectives Based on the results a previous pilot study, objective present study...

10.1111/j.1365-2133.2007.07974.x article EN British Journal of Dermatology 2007-06-06

A new 8% ciclopirox-medicated nail lacquer (P-3051), based on a technology, revealed superior properties in terms of affinity to keratin, permeation, and ease use.This study aims assess the efficacy safety P-3051 vs. market ciclopirox lacquer.This is multicentre, randomized, three-arm, placebo-controlled, parallel groups, evaluator-blinded study. Overall, 467 patients with onychomycosis at least one big toenail were randomized receive P-3051, reference drug or placebo 2 : 1 ratio for 48-week...

10.1111/j.1468-3083.2009.03164.x article EN Journal of the European Academy of Dermatology and Venereology 2009-05-05

Abstract Background The chronic and treatment‐resistant nature of nail psoriasis affects patients’ lives not only physically but also psychologically. Although there are scoring systems available for disease severity, is as yet no scale to evaluate the impact this condition upon quality life. Objectives This study aims develop validate a life specifically psoriasis. Methods A questionnaire was developed during conducted in France between 2004 2005. With cooperation l’Association Pour la...

10.1111/j.1468-3083.2009.03344.x article EN Journal of the European Academy of Dermatology and Venereology 2009-07-03
Coming Soon ...